JP JAZZ PHARMACEUTICALS

House mark for a line of pharmaceuticals for the treatment, management and prevention of cancer, psychiatric diseases and disorders, central nervous system conditions, sleep disorders, narcolepsy, schizophrenia, cataplexy, obstructive sleep apnea, and for use in oncological and hematological diseases and disorders; Pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for use in oncology and hematology; pharmaceutical preparations for the treatment and management of neurological, psychiatric, and sleep conditions, diseases, and disorders; pharmaceutical preparations for the treatment and management of cancer, cataplexy, excessive daytime sleepiness, liver disease, narcolepsy, obstructive sleep apnea, and schizophrenia